Skip to content

Robotic Minimally Invasive Inguinal Hernia Repair With Dexter

Robotic Minimally Invasive Inguinal Hernia Repair With Dexter

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05873582
Acronym
RAS-Ahead
Enrollment
50
Registered
2023-05-24
Start date
2023-06-02
Completion date
2023-10-23
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia Repair

Brief summary

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair.

Interventions

Primary transperitoneal unilateral or bilateral inguinal hernia repair with the Dexter robotic system

Sponsors

Confinis
CollaboratorINDUSTRY
Distalmotion SA
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Aged \> 18 years * Patients planned to undergo elective robot-assisted and laparoscopic surgery for primary unilateral or bilateral inguinal hernia repair using one camera port, two ports for the manipulating instruments, and additional ports as needed. * Able to provide Informed Consent according to local regulation

Exclusion criteria

* Morbidly obese patients (BMI \> 40) * Any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments * Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery * Bleeding diathesis * Pregnancy * Patients with pacemakers or internal defibrillators * Any planned concomitant procedures * Patient deprived of liberty by administrative or judicial decision or under legal guardianship * Participation in another interventional clinical trial

Design outcomes

Primary

MeasureTime frame
Safety: occurrence of serious (Clavien - Dindo grades III-V), device-related, adverse eventsperioperatively up to 30 days
Performance: successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approachintraoperative

Countries

France, Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026